'Naye Bharat Ki Nayi Khadi': KVIC highlights innovation and contemporary design (See 'Corp Brief') Misc - Inclusion of royalty, DMF and NMET in sale value under Mineral Conservation and Development Rules, 2017, is valid measure for computation of average sale price and does not alter nature of royalty u/s 9 of MMDR Act: SC (See 'Legal Desk') IICA, DG Resettlement hold 5th Batch of Directors' Certification in Corporate Governance (See 'Corp Brief') DIBD, PNB sign MoU to advance Multilingual AI for Inclusive Banking (See 'Corp Brief') IBC - Refund of court fees cannot be denied merely because dispute was resolved through CIRP framework rather than through formal court-referred process u/s 89 CPC: HC (See 'Legal Desk') BRICS Nations adopt Landmark Declaration on Labour and Employment (See 'Corp Brief') PMLA - Appellant cannot bypass strict statutory timelines of PMLA by filing defective appeal & allowing it to continue for seven months under guise of re-filing: HC (See 'Legal Desk') India Mining Week 2026 to be held in November 15-17 (See 'Corp Brief') A&C - Debarment letter issued by AAI is administrative order arising from AAI's independent statutory and administrative powers, and not contractual measure under construction contract: HC (See 'Legal Desk') Cabinet approves two multitracking projects covering Four Districts across Odisha and Jharkhand (See 'Corp Brief') Ministry of Mines to launch 8th Tranche of Auction of Critical and Strategic Mineral Blocks (See 'Corp Brief') IPR - In copyright action involving logos, mere visual resemblance and prior adoption are not enough to justify interim relief, and reasonable possibility of access and prima facie causal link must be shown: HC (See 'Legal Desk') BIS hosts Heads of National Standardization Bodies of BRICS (See 'Corp Brief') Geo-spatial mapping of India-Myanmar border is in progress: MoS (See 'Corp Brief') Copyright - Purpose of proviso to Section 45(1) of Act is to maintain purity of register & prevent unscrupulous entities from evading trademark law by seeking shelter under false claims of copyright ownership over artistic work that mirrors another's registered trademark: HC (See 'Legal Desk') Bharat Tex 2026: Where India's Textile Vision meets the World's Trade Ambition (See 'Corp Brief') India Post records Highest-Ever Q1 Revenue of Rs.4,000 Crores (See 'Corp Brief') IPR - Confusion among consumers in pharmaceutical matters can be extremely detrimental, especially in relation to antibiotics: HC (See 'Legal Desk') NSFDC showcases success in bolstering entrepreneurship amongst depressed classes (See 'Corp Brief') Govt reviews BSNL performance for Q1 FY 2026-27 (See 'Corp Brief') India enters next phase of governance transformation with AI-driven administrative reforms: MoS (See 'Corp Brief') IPR - If infringing use is coupled alleged fraudulent online payment & earning schemes, conduct may be treated not merely as trademark infringement and passing off, but also as phishing & cyber fraud justifying urgent intervention: HC (See 'Legal Desk') MeitY releases 2nd edition of the Digital Threat Report 2025-26 for BFSI Sector (See 'Corp Brief') On Eve of Bharat Tex 2026, India prepares to host World's Largest Global Textiles Expo (See 'Corp Brief') IPR - In vitro screening method functions as diagnostic process, which is barred from patentability u/s 3(i) of Patents Act: HC (See 'Legal Desk') 'SANKALP' to guide CPWD's Journey towards Future-Ready Organisation: Union Minister (See 'Corp Brief') Healthcare facilities worth Rs 668 Crore to benefit 53 Lakh ESI Beneficiaries (See 'Corp Brief') Chouhan gives message of Green India during dialogue with Vriksh Mitra (See 'Corp Brief') IPR - If on visual comparison, rival medicinal marks are strikingly similar in essential features, overall get up and packaging, and where trade channels and consumer base are common, likelihood of deception is sufficient to justify interim injunction: HC (See 'Legal Desk') Lakhanpur among first towns selected under PM SVANidhi 'Street Food Hub' Plan: MoS (See 'Corp Brief') Paswan hails PMFME Scheme's landmark achievement of 2 lakh Credit-Linked Beneficiaries (See 'Corp Brief') 500 officials participate in inaugural webinar on Anemia and Adolescent Health (See 'Corp Brief') IPR - Purpose of summary judgment in commercial suits is to ensure time-bound disposal and that trial is not default norm: HC (See 'Legal Desk') Ministry of Textiles to organise 'Weave The Future 4.0 - Upcycling Edition' at Dilli Haat (See 'Corp Brief') IPR - For purposes of Sec 57 of Trade Marks Act, foreign proprietor may succeed in rectification by proving that its mark had acquired actionable recognition, even without formal commercial launch or direct sales: HC (See 'Legal Desk') Nadda chairs Steering Group Meeting of Ayushman Bharat Digital Mission (See 'Corp Brief') DoP and TRAI to conduct Village-Level Telecom Network Performance Survey (See 'Corp Brief') IBC - Demand notice in Form B under Rule 7(1) of Personal Guarantor Rules is only procedural requirement prior to filing and does not amount to invocation of guarantee: NCLT (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT')

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.